Measures that could have been taken at the beginning of the pandemic were not implemented as precautionary preparation but rather as reactionary to an already spreading virus, making it hard to contain.
SARS-CoV-2 antibodies were found in patients’ blood up to 7 months after infection, and researchers are hopeful.
A small trial indicates that Moderna’s experimental SARS-CoV-2 vaccine is effective and safe in older adults, a population group most vulnerable to severe COVID-19.
Where pneumococcal vaccination rates are high, COVID-19 cases are low and vice-versa.
Researchers capture high-powered microscopic images showing startlingly high SARS-CoV-2 viral loads on human respiratory surfaces.
The global trial run by researchers at Oxford and AstraZeneca has been paused due to an adverse reaction at a UK site. Whether the reaction is related to the vaccine is still unknown.
Face shields and masks with exhalation valves found to be ineffective for stopping COVID-19 from spreading.
Study claims nasal delivery protects first site of infection and produces widespread immune response compared to intramuscular injection.
Comprehensive pediatric study examines viral load, immune response and hyperinflammation in pediatric COVID-19.
Trials need more people of color to generalize results to larger US population.
Research reveals regrettably little health information in coronavirus-tagged videos.
CU Denver researcher investigates how South Korean policy enabled the country to flatten the curve without economic disaster.
An extensive study carried out on SARS-CoV-2 sequencing reveals six strains of the virus.